Virtus KAR Health Sciences Fund
Fund
RAGHX
Price as of:
$26.71
- $0.41
- 1.51%
Primary Theme
fund company
Name
As of 06/01/2026Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
Vitals
YTD Return
-10.0%
1 yr return
2.9%
3 Yr Avg Return
-0.4%
5 Yr Avg Return
-0.2%
Net Assets
$87.6 M
Holdings in Top 10
55.8%
52 WEEK LOW AND HIGH
$27.1
N/A
N/A
Expenses
OPERATING FEES
Expense Ratio 1.40%
SALES FEES
Front Load 5.50%
Deferred Load N/A
TRADING FEES
Turnover N/A
Redemption Fee N/A
Min Investment
Standard (Taxable)
$2,500
IRA
$100
Fund Classification
Fund Type
Open End Mutual Fund
Name
As of 06/01/2026Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
RAGHX - Profile
Distributions
- YTD Total Return -10.0%
- 3 Yr Annualized Total Return -0.4%
- 5 Yr Annualized Total Return -0.2%
- Capital Gain Distribution Frequency Annually
- Net Income Ratio -0.04%
- Dividend Yield 0.0%
- Dividend Distribution Frequency Annual
Fund Details
-
Legal NameVirtus KAR Health Sciences Fund
-
Fund Family NameAllianz Funds
-
Inception DateDec 22, 2014
-
Shares OutstandingN/A
-
Share ClassA
-
CurrencyUSD
-
Domiciled CountryUS
-
ManagerPeter Pirsch
Fund Description
p style="font-size:9.5pt; font-family:Sans-Serif; text-align:left; color:#000000; font-weight:normal; text-decoration:none;"The fund pursues long-term capital appreciation in health sciences-related companies. The fund invests in a select group of health science-related companies believed by the fund’s subadviser to possess sustainable competitive advantages at prices the subadviser deems attractive. /pp style="font-size:9.5pt; font-family:Sans-Serif; text-align:left; color:#000000; font-weight:normal; text-decoration:none;"The fund seeks to achieve its objective by normally investing at least 80% of its net assets (plus borrowings made for investment purposes) in health sciences-related companies. The fund considers health sciences-related companies to include companies that design, manufacture or sell products or services used for or in connection with healthcare, medicine or life sciences. The fund will invest primarily in common stocks and other equity securities. Although the fund may invest in companies of any market capitalization, the fund does not currently intend to invest more than 15% of its assets in companies with market capitalizations below $1 billion. The fund may invest in U.S. and non-U.S. companies. The fund may invest in securities issued in initial public offerings (IPOs). Generally, the fund invests in approximately 25 to 40 securities at any given time./p
Read More
RAGHX - Performance
Return Ranking - Trailing
| Period | RAGHX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | -10.0% | -22.9% | 20.0% | 98.13% |
| 1 Yr | 2.9% | -20.4% | 134.5% | 96.88% |
| 3 Yr | -0.4%* | -6.3% | 23.9% | 97.50% |
| 5 Yr | -0.2%* | -15.5% | 12.3% | 89.03% |
| 10 Yr | 6.0%* | 3.0% | 13.1% | 92.13% |
* Annualized
Return Ranking - Calendar
| Period | RAGHX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2025 | 7.2% | -21.9% | 61.0% | 72.50% |
| 2024 | -3.1% | -28.2% | 19.2% | 58.13% |
| 2023 | 3.4% | -8.6% | 19.0% | 42.50% |
| 2022 | -19.4% | -53.9% | 3.2% | 84.52% |
| 2021 | 2.4% | -39.6% | 24.2% | 40.00% |
Total Return Ranking - Trailing
| Period | RAGHX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | -10.0% | -22.9% | 20.0% | 98.13% |
| 1 Yr | 2.9% | -20.4% | 134.5% | 96.88% |
| 3 Yr | -0.4%* | -6.3% | 23.9% | 97.50% |
| 5 Yr | -0.2%* | -15.5% | 12.3% | 89.03% |
| 10 Yr | 6.0%* | 3.0% | 13.1% | 92.13% |
* Annualized
Total Return Ranking - Calendar
| Period | RAGHX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2025 | 7.2% | -0.5% | 63.7% | 94.38% |
| 2024 | -3.1% | -28.2% | 19.2% | 92.50% |
| 2023 | 3.4% | -8.6% | 19.0% | 66.25% |
| 2022 | -11.8% | -53.9% | 3.7% | 58.06% |
| 2021 | 25.4% | -33.9% | 26.0% | 1.94% |
NAV & Total Return History
RAGHX - Holdings
Concentration Analysis
| RAGHX | Category Low | Category High | RAGHX % Rank | |
|---|---|---|---|---|
| Net Assets | 87.6 M | 6.38 M | 37.9 B | 78.13% |
| Number of Holdings | 24 | 24 | 416 | 100.00% |
| Net Assets in Top 10 | 50.1 M | 3.49 M | 22.8 B | 72.50% |
| Weighting of Top 10 | 55.85% | 16.2% | 79.4% | 13.13% |
Top 10 Holdings
- Eli Lilly Co. COM 13.30%
- Mckesson Corp. COM 5.57%
- Vertex Pharmaceuticals Incorporated COM 5.09%
- AbbVie Inc. COM 5.09%
- Merck Co., Inc COM 5.05%
- Intuitive Surgical Inc. COM NEW 4.80%
- West Pharmaceutical Services Incorporated COM 4.40%
- IDEXX Laboratories Inc. COM 4.29%
- Mettler-Toledo International Inc COM 4.20%
- The Cooper Companies, Inc. COM 4.05%
Asset Allocation
| Weighting | Return Low | Return High | RAGHX % Rank | |
|---|---|---|---|---|
| Stocks | 99.17% | 88.27% | 106.13% | 37.50% |
| Cash | 0.83% | 0.00% | 32.31% | 58.13% |
| Preferred Stocks | 0.00% | 0.00% | 7.86% | 83.13% |
| Other | 0.00% | -22.99% | 4.13% | 78.13% |
| Convertible Bonds | 0.00% | 0.00% | 0.37% | 78.06% |
| Bonds | 0.00% | 0.00% | 12.39% | 80.00% |
Stock Sector Breakdown
| Weighting | Return Low | Return High | RAGHX % Rank | |
|---|---|---|---|---|
| Healthcare | 96.35% | 59.26% | 100.00% | 94.84% |
| Basic Materials | 2.90% | 0.00% | 7.16% | 4.52% |
| Consumer Defense | 0.74% | 0.00% | 25.73% | 3.23% |
| Utilities | 0.00% | 0.00% | 0.00% | 75.48% |
| Technology | 0.00% | 0.00% | 22.69% | 78.71% |
| Real Estate | 0.00% | 0.00% | 5.89% | 76.77% |
| Industrials | 0.00% | 0.00% | 7.02% | 78.06% |
| Financial Services | 0.00% | 0.00% | 1.60% | 82.58% |
| Energy | 0.00% | 0.00% | 0.00% | 75.48% |
| Communication Services | 0.00% | 0.00% | 9.11% | 75.48% |
| Consumer Cyclical | 0.00% | 0.00% | 1.92% | 76.77% |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | RAGHX % Rank | |
|---|---|---|---|---|
| US | 99.17% | 60.50% | 104.41% | 21.25% |
| Non US | 0.00% | 0.00% | 36.86% | 91.25% |
RAGHX - Expenses
Operational Fees
| RAGHX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 1.40% | 0.08% | 4.69% | 35.00% |
| Management Fee | 0.80% | 0.03% | 1.25% | 66.88% |
| 12b-1 Fee | 0.25% | 0.00% | 1.00% | 49.33% |
| Administrative Fee | 0.10% | 0.03% | 0.25% | 36.11% |
Sales Fees
| RAGHX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | 5.50% | 3.50% | 5.75% | 66.67% |
| Deferred Load | N/A | 1.00% | 1.00% | N/A |
Trading Fees
| RAGHX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | 1.00% | 1.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| RAGHX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | N/A | 1.00% | 238.00% | 91.19% |
RAGHX - Distributions
Dividend Yield Analysis
| RAGHX | Category Low | Category High | RAGHX % Rank | |
|---|---|---|---|---|
| Dividend Yield | 0.00% | 0.00% | 6.24% | 83.75% |
Dividend Distribution Analysis
| RAGHX | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | Annual | Annual | Annual | Annual |
Net Income Ratio Analysis
| RAGHX | Category Low | Category High | RAGHX % Rank | |
|---|---|---|---|---|
| Net Income Ratio | -0.04% | -2.54% | 1.85% | 36.60% |
Capital Gain Distribution Analysis
| RAGHX | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Annually | Annually | Semi-Annually | Annually |
Distributions History
| Date | Amount | Type |
|---|---|---|
| Dec 21, 2022 | $2.627 | CapitalGainLongTerm |
| Dec 16, 2021 | $7.485 | OrdinaryDividend |
| Dec 17, 2020 | $4.852 | OrdinaryDividend |
| Dec 19, 2019 | $0.002 | OrdinaryDividend |
| Dec 19, 2019 | $0.614 | CapitalGainShortTerm |
| Dec 19, 2019 | $1.710 | CapitalGainLongTerm |
| Dec 20, 2018 | $0.317 | OrdinaryDividend |
| Dec 20, 2018 | $0.253 | CapitalGainShortTerm |
| Dec 20, 2018 | $4.024 | CapitalGainLongTerm |
| Dec 10, 2015 | $1.938 | CapitalGainShortTerm |
| Dec 10, 2015 | $4.883 | CapitalGainLongTerm |
| Dec 11, 2014 | $2.984 | CapitalGainShortTerm |
| Dec 11, 2014 | $1.976 | CapitalGainLongTerm |
| Dec 12, 2013 | $1.928 | CapitalGainShortTerm |
| Dec 12, 2013 | $4.155 | CapitalGainLongTerm |
| Dec 13, 2012 | $2.188 | CapitalGainLongTerm |
| Dec 15, 2011 | $2.718 | CapitalGainLongTerm |
RAGHX - Fund Manager Analysis
Managers
Peter Pirsch
Start Date
Tenure
Tenure Rank
Mar 22, 2018
4.19
4.2%
Mr. Pirsch is a senior portfolio manager, a senior analyst and a director with Allianz Global Investors, which he joined in 2018. He has management and research responsibilities for the Health Care team. Mr. Pirsch has 20 years of investment-industry experience. He previously worked at Aptigon Capital, Visium Asset Management, Surveyor Capital, Fred Alger Management and C.R. Bard. Before that, Mr. Pirsch was an associate director at UBS Investment Bank and an analyst at Wells Fargo. He has a B.A. in economics and international relations from Bucknell University, and an M.B.A. with a certificate in health sector management from Duke University, Fuqua School of Business. Mr. Pirsch is a CFA charterholder.
Christopher Chin
Start Date
Tenure
Tenure Rank
Aug 27, 2020
1.76
1.8%
Tenure Analysis
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 0.02 | 24.72 | 8.08 | 0.25 |